| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-03699-20ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35296-1mg | |||
| Carrier-Free | NBP2-35296-100ug | |||
| Carrier-Free | NBP2-35296-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35033-1mg | |||
| Carrier-Free | NBP2-35033-100ug | |||
| Carrier-Free | NBP2-35033-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-59638-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-12274-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-11921-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-12306-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-12297-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NB110-60995-0.025mg | |||
![Western Blot: NRARP Overexpression Lysate (Adult Normal) [NBL1-13784] Left-Empty vector transfected control cell lysate (HEK293 cell lysate); Right -Over-expression Lysate for NRARP.](http://images.novusbio.com/fullsize/NRARP-Overexpression-Lysate-Adult-Normal-Western-Blot-NBL1-13784-img0002.jpg "Western Blot: NRARP Overexpression Lysate (Adult Normal) [NBL1-13784] Left-Empty vector transfected control cell lysate (HEK293 cell lysate); Right -Over-expression Lysate for NRARP.")
![Western Blot: NRARP Overexpression Lysate (Adult Normal) [NBL1-13784] - Western Blot experiments. Left-Control; Right -Over-expression Lysate for NRARP](http://images.novusbio.com/fullsize/NRARP-Overexpression-Lysate-Adult-Normal-Western-Blot-NBL1-13784-img0001.jpg)
![Western Blot: KGF/FGF-7 Antibody (4L2O8) [NBP3-16623] - Western blot analysis of extracts of various cell lines, using FGF7/KGF/FGF-7 Rabbit mAb (NBP3-16623) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 60s.](http://images.novusbio.com/fullsize/KGF-FGF-7-Antibody-4L2O8-Western-Blot-NBP3-16623-img0001.jpg "Western Blot: KGF/FGF-7 Antibody (4L2O8) [NBP3-16623] - Western blot analysis of extracts of various cell lines, using FGF7/KGF/FGF-7 Rabbit mAb (NBP3-16623) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 60s.")
![Western Blot:FGFR2 Overexpression Lysate[NBP2-04149]](http://images.novusbio.com/fullsize/nbp2-07774_ctla-4-overexpression-lysate-western-blot-181202613311113.jpg "Western Blot:FGFR2 Overexpression Lysate[NBP2-04149]")
![Western Blot:FGFR2 Overexpression Lysate[NBP2-04149]](http://images.novusbio.com/fullsize/nbp2-04149_fgfr2-overexpression-lysate-western-blot-18120261618188.jpg)
![Western Blot: IL-18/IL-1F4 Antibody [NBP3-03699] - Analysis of extracts of various cell lines, using IL18 antibody at 1:1000 dilution.Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution.Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST.Detection: ECL Enhanced Kit. Exposure time: 180s.](http://images.novusbio.com/fullsize/IL-18-IL-1F4-Antibody-Western-Blot-NBP3-03699-img0003.jpg "Western Blot: IL-18/IL-1F4 Antibody [NBP3-03699] - Analysis of extracts of various cell lines, using IL18 antibody at 1:1000 dilution.Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution.Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST.Detection: ECL Enhanced Kit. Exposure time: 180s.")
![Immunoprecipitation: IL-18/IL-1F4 Antibody [NBP3-03699] - Analysis of 200ug extracts of HeLa cells, using IL-18/IL-1F4 antibody . Western blot was performed from the immunoprecipitate using this antibody.](http://images.novusbio.com/fullsize/IL-18-IL-1F4-Antibody-Immunoprecipitation-NBP3-03699-img0001.jpg)
![SDS-Page: Rat FGF18 Protein [NBP2-35296]](http://images.novusbio.com/fullsize/Rat-FGF18-Protein-SDS-Page-NBP2-35296-img0001.jpg "SDS-Page: Rat FGF18 Protein [NBP2-35296]")
![SDS-Page: Mouse FGF-8 Protein [NBP2-35033]](http://images.novusbio.com/fullsize/Mouse-FGF-8-Protein-SDS-Page-NBP2-35033-img0001.jpg "SDS-Page: Mouse FGF-8 Protein [NBP2-35033]")
![Immunohistochemistry-Paraffin: Endostatin Antibody (RM0060-3H11) [NBP2-12274] - Paraffin lung and spleen secttions from LPS treated mice were subjected to IHC using anti Endostatin antibody.](http://images.novusbio.com/fullsize/Endostatin-Antibody-RM0060-3H11-Immunohistochemistry-Paraffin-NBP2-12274-img0001.jpg "Immunohistochemistry-Paraffin: Endostatin Antibody (RM0060-3H11) [NBP2-12274] - Paraffin lung and spleen secttions from LPS treated mice were subjected to IHC using anti Endostatin antibody.")
![Immunohistochemistry-Paraffin: TGF-beta RI/ALK-5 Antibody (RM0016-3A11) [NBP2-11921] - Parrafin lung and kidney sections from LPS treated mice using anti ALK5 antibody.](http://images.novusbio.com/fullsize/TGF-beta-RI-ALK-5-Antibody-RM0016-3A11-Immunohistochemistry-Paraffin-NBP2-11921-img0002.jpg "Immunohistochemistry-Paraffin: TGF-beta RI/ALK-5 Antibody (RM0016-3A11) [NBP2-11921] - Parrafin lung and kidney sections from LPS treated mice using anti ALK5 antibody.")
![Immunohistochemistry-Paraffin: FGF-9 Antibody (MM0292-4D25) [NBP2-12306] - 10% Buffer formalin fixed and parffine embedded human placetal tissue section (4um) is subjected IHC staining using NBP2-12306. Tissue section was pretreated in citric buffer (pH 6.0) with microwave for antige retrieval before IHC is applied.](http://images.novusbio.com/fullsize/FGF-9-Antibody-MM0292-4D25-Immunohistochemistry-Paraffin-NBP2-12306-img0001.jpg "Immunohistochemistry-Paraffin: FGF-9 Antibody (MM0292-4D25) [NBP2-12306] - 10% Buffer formalin fixed and parffine embedded human placetal tissue section (4um) is subjected IHC staining using NBP2-12306. Tissue section was pretreated in citric buffer (pH 6.0) with microwave for antige retrieval before IHC is applied.")
![Immunohistochemistry-Paraffin: FGF-16 Antibody (MM0283-6G2) [NBP2-12297] - 10% Buffer formalin fixed and parffine embedded human placetal tissue section (4um) is subjected IHC staining using NBP2-12297. Tissue section was pretreated in citric buffer (pH 6.0) with microwave for antige retrieval before IHC is applied.](http://images.novusbio.com/fullsize/FGF-16-Antibody-MM0283-6G2-Immunohistochemistry-Paraffin-NBP2-12297-img0001.jpg "Immunohistochemistry-Paraffin: FGF-16 Antibody (MM0283-6G2) [NBP2-12297] - 10% Buffer formalin fixed and parffine embedded human placetal tissue section (4um) is subjected IHC staining using NBP2-12297. Tissue section was pretreated in citric buffer (pH 6.0) with microwave for antige retrieval before IHC is applied.")
![Immunohistochemistry-Paraffin: MMP25 Antibody (MM0029-2B5) [NB110-60995] - Human placenta (formalin fixed and paraffin embedded) section is subjected to IHC.](http://images.novusbio.com/fullsize/MMP25-Antibody-MM0029-2B5-Immunohistochemistry-Paraffin-NB110-60995-img0001.jpg "Immunohistochemistry-Paraffin: MMP25 Antibody (MM0029-2B5) [NB110-60995] - Human placenta (formalin fixed and paraffin embedded) section is subjected to IHC.")